Philip Morris International Inc. quarterly report, Q3 FY2010

Philip Morris International Inc. — Q3 2010 Form 10-Q

Reporting period: Three and nine months ended September 30, 2010; unaudited. PMI manufactures and sells tobacco products outside the United States across four geographic segments. Unless noted otherwise, amounts are U.S. dollars.

Financial performance

MetricQ3 2010Q3 2009Nine months 2010Nine months 2009
Net revenues$16.936B$16.573B$49.906B$45.072B
Net revenues excluding excise taxes$6.614B$6.587B$20.171B$18.318B
Operating income$2.836B$2.850B$8.457B$7.599B
Net earnings attributable to PMI$1.822B$1.798B$5.507B$4.820B
Diluted EPS$0.99$0.93$2.96$2.44
Operating cash flowNot separately providedNot separately provided$7.856B$6.419B

Q3 revenue rose 2.2%, but revenue excluding excise taxes increased just 0.4%; operating income declined 0.5%, while PMI-attributable earnings rose 1.3% and diluted EPS rose 6.5%. For the first nine months, revenue increased 10.7% and revenue excluding excise taxes rose 10.1%; operating income increased 11.3%, PMI-attributable earnings 14.3%, and diluted EPS 21.3%. Reported revenue includes excise taxes collected from customers. The reported operating margin was approximately 16.7% in Q3 and 17.0% year to date.

For the first nine months, cigarette shipments increased 4.5% to 674.9 billion units, but were down 1.6% excluding acquisitions. Q3 shipments rose 4.5%, but fell 2.9% excluding acquisitions. The Philippines combination contributed substantially to shipment growth; Q3 Japan shipments were affected by payback of distributor inventory accumulated ahead of an October tax-driven price increase.

Cash, debt and capital allocation

  • Cash and cash equivalents were $3.507B at September 30, 2010, versus $1.540B at December 31, 2009. Nine-month investing cash outflow was $446M and financing cash outflow was $5.507B.
  • Total debt was approximately $17.4B, compared with $15.4B at year-end 2009; this includes $2.416B of short-term borrowings and $1.436B of current long-term debt. Long-term debt was $13.595B.
  • Committed revolving credit facilities totaled $5.2B, with no borrowings outstanding under those facilities. The company reported a 13.6-to-1 covenant EBITDA-to-interest ratio against a 3.5-to-1 minimum.
  • Nine-month cash uses included $3.863B of share repurchases and $3.254B of dividends paid. PMI announced an intention to accelerate 2010 repurchases to approximately $5.0B. The quarterly dividend was increased 10.3% to $0.64 per share, or an annualized $2.56.
  • Current assets were $15.482B and current liabilities $13.713B at September 30. The filing does not provide a separate management conclusion on short-term liquidity adequacy.

Material changes and unusual items

  • Year-to-date revenue growth excluding excise taxes reflected net pricing (+$1.1B), favorable currency (+$734M) and acquisitions (+$460M), partly offset by lower volume/mix (-$423M). Operating income benefited from pricing, currency and acquisitions, while lower volume/mix and higher manufacturing and overhead costs were offsets.
  • Q3 revenue excluding excise taxes was nearly flat: pricing and acquisitions were largely offset by lower volume/mix and unfavorable currency. Q3 operating income was pressured chiefly by lower volume/mix, partly offset by pricing.
  • The effective tax rate was 27.0% for the first nine months, versus 29.3% a year earlier. A $148M reversal of tax reserves after the conclusion of an IRS examination benefited the 2010 rate; Greek tax-rate changes and an Italian audit partly offset the benefit. Management estimated a 28.6% full-year 2010 rate excluding those discrete items.
  • PMI recorded $20M of asset impairment and exit costs in the first nine months, primarily factory restructuring in Greece and Portugal; approximately $51M of future exit-cost payments were expected through 2012. The 2009 comparison included a $135M pre-tax charge for the Colombian Investment and Cooperation Agreement.
  • The February 2010 Philippines business combination with Fortune Tobacco is consolidated by PMI despite equal economic interests, based on PMI’s operational control and board majority. FTC’s redeemable noncontrolling interest was $1.199B at September 30. A decline in the fair value of FTC’s interest below its $1.17B redemption value could reduce PMI EPS.

Outlook, commentary and risks

On October 21, 2010, PMI raised and narrowed its full-year 2010 diluted EPS forecast to $3.90–$3.95, approximately 20%–22% above 2009; excluding currency, growth was projected at approximately 16%–18%. The forecast included $0.07 per share from the tax-reserve reversal and $0.01 per share of restructuring costs, and excluded potential future acquisitions, additional impairment or exit charges, and unusual events. Management cited favorable currency at prevailing rates, improved business performance and a lower tax rate.

Management identified continuing exposure to excise-tax increases, regulation of products and marketing, plain-packaging proposals, litigation, illicit trade, competition, currency movements, changing consumer preferences and agricultural input costs. PMI reported that it had not accrued losses for pending tobacco-related cases because management had not concluded losses were probable or could be reasonably estimated; adverse outcomes could nevertheless materially affect results or liquidity. A Thai investigation concerned alleged customs-duty and excise-tax underpayments of approximately $2.0B for 2003–2007, with a separate informal inquiry concerning approximately $1.8B for 2000–2003. These were allegations, not recorded liabilities.

PMI’s proposed $452M acquisition of Colombia’s Protabaco received conditional regulatory approval in October 2010; PMI was reviewing significant conditions and had not decided whether to proceed. The filing also described a new EU tobacco-products review and proposed Australian plain-packaging legislation. Management stated that outcomes and effects of these regulatory developments could not be predicted.

Most important facts for investors to verify

  • Whether the $3.90–$3.95 full-year EPS forecast was achieved, and how currency, tax benefits and share repurchases contributed to reported growth.
  • Underlying shipment and earnings trends excluding acquisitions, particularly the impact of tax-driven price increases and inventory timing in Japan, Turkey and Europe.
  • Debt and cash-flow trajectory alongside planned buybacks and the increased dividend.
  • Developments in the Thai tax investigation, tobacco litigation, and the potential EPS implications of the Philippines redeemable noncontrolling interest.
  • Whether PMI proceeded with the conditional Protabaco acquisition and whether evolving tobacco regulation affected its business or costs.